Loading clinical trials...
Loading clinical trials...
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer)
Conditions
Interventions
HCL
verapamil 120mg tablet
+2 more
Locations
6
United States
Stanford University
Palo Alto, California, United States
Barbara Davis Center
Aurora, Colorado, United States
Yale University
New Haven, Connecticut, United States
Indiana University
Indianapolis, Indiana, United States
University of Minnesota
Minneapolis, Minnesota, United States
Children's Mercy Hospital
Kansas City, Missouri, United States
Start Date
July 9, 2020
Primary Completion Date
September 15, 2022
Completion Date
September 30, 2022
Last Updated
November 27, 2024
NCT03648918
NCT06408207
NCT05777330
NCT03811470
NCT07319286
NCT03782636
Lead Sponsor
Jaeb Center for Health Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions